SCHEMBL830579

SCHEMBL830579

CC(O)CCCCCCCCCCO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
TSHR P16473 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
TRPA1 O75762 1/20 0.42
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PSMD14 O00487 2/20 0.36
PLA2G1B P04054 2/20 0.36
MMP2 P08253 2/20 0.36
ATG4B Q9Y4P1 2/20 0.36
HSP90AA1 P07900 1/20 0.36
RAD52 P43351 1/20 0.36
SPHK1 Q9NYA1 2/20 0.36
GMNN O75496 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8077217 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL428372 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL424124 1.00
SCHEMBL13202549 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL19411359 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
1,6-Hexanediol SCHEMBL15347446 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL554360 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL10406986 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL5398466 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL12491774 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116515174-A Starch-based degradable composite material and preparation method and application thereof 西达(无锡)生物科技有限公司 2023-08-01 CN claimed
WO-2017171674-A1 SYNTHESIS OF ATTRACTANT OF PISTACHIO TWIG BORER (KERMANIA PISTACIELLA) ABDULKADIR SIRIT (TR) 2017-10-05 WO claimed
EP-4225822-B1 METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS COVESTRO DEUTSCHLAND AG (DE) 2026-05-13 EP disclosed
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives GENOMATICA, INC. (US) 2026-04-07 US disclosed
EP-4706956-A1 LAMINATION STRUCTURE FOR RETORT APPLICATIONS Siegwerk Druckfarben AG & Co. KGaA (DE) 2026-03-11 EP disclosed
EP-4705367-A1 LAMINATION ADHESIVE Bostik SA (FR) 2026-03-11 EP disclosed
EP-4706954-A1 DEBONDABLE LAMINATION STRUCTURE FOR RETORT APPLICATION Siegwerk Druckfarben AG & Co. KGaA (DE) 2026-03-11 EP disclosed
US-12545823-B2 Lamination adhesive for sterilisation BOSTIK SA (FR) 2026-02-10 US disclosed
US-20260002061-A1 TWO-COMPONENT COMPOSITION BOSTIK SA (FR) 2026-01-01 US disclosed
EP-4561827-A1 RECYCLED ARTICLE AND USES THEREOF Bostik SA (FR) 2025-06-04 EP disclosed
EP-4561828-A1 ADHESIVE COMPOSITION Bostik SA (FR) 2025-06-04 EP disclosed
US-20030091924-A1 Image forming method FUJI XEROX CO., LTD. (JP) 2003-05-15 US disclosed
EP-1007206-A4 PHOSPHORUS/VANADIUM CATALYST PREPARATION SCIENT DESIGN CO (US) 2002-05-15 EP disclosed
EP-1007206-A1 PHOSPHORUS/VANADIUM CATALYST PREPARATION Scientific Design Company Inc. (US) 2000-06-14 EP disclosed
WO-1999006143-A1 PHOSPHORUS/VANADIUM CATALYST PREPARATION SCIENTIFIC DESIGN COMPANY, INC. (US) 1999-02-11 WO disclosed
US-4668550-A OPTICAL RECORDING MEDIA HITACHI, LTD. (JP) 1987-05-26 US disclosed
EP-0213307-A2 Optical disc HITACHI, LTD. (JP) 1987-03-11 EP disclosed
EP-0146053-A2 Chemical process for preparing antibiotic L 17392 (Deglucoteicoplanin) and its salts GRUPPO LEPETIT S.p.A. (IT) 1985-06-26 EP disclosed
EP-0057825-B1 PROCESS FOR THE PREPARATION OF ALIPHATIC CYCLIC CARBONATES BAYER AG (DE) 1984-10-03 EP disclosed
EP-0057825-A1 Process for the preparation of aliphatic cyclic carbonates BAYER AG (DE) 1982-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545823-B2 Lamination adhesive for sterilisation C9, CDH1, RCC1 LMNA 179/4885TSHR 4643/4885ALDH1A1 724/4885
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives CYP4F11, CYP2F1, CYP4Z1 LMNA 3439/4885TSHR 1330/4885ALDH1A1 327/4885
US-20260002061-A1 TWO-COMPONENT COMPOSITION SDC2, C9, SDAD1 LMNA 1527/4885TSHR 3877/4885ALDH1A1 2149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.